Clearside Biomedical Inc

NASDAQ:CLSD  
5.73
+0.13 (+2.32%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)347.51M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.58 Million
Adjusted EPS-$0.09
See more estimates
10-Day MA$5.61
50-Day MA$6.11
200-Day MA$4.24
See more pivots

Clearside Biomedical Inc Stock, NASDAQ:CLSD

900 North Point parkway, Suite 200, Alpharetta, Georgia 30005
United States of America
Phone: +1.678.270.3631
Number of Employees: 33

Description

Clearside Biomedical, Inc. is a biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.